Speckle tracking echocardiography detects uremic cardiomyopathy early and predicts cardiovascular mortality in ESRD

Journal of the American Society of Nephrology

Volumn 25, Issue 10, 2014, Pages 2351-2365

  Kramann, Rafael ^a   Erpenbeck, Johanna ^a   Schneider, Rebekka K ^a   Röhl, Anna B ^a   Hein, Marc ^a   Brandenburg, Vincent M ^a   Van Diepen, Merel ^b   Dekker, Friedo ^b   Marx, Nicolaus ^a   Floege, Jürgen ^a   Becker, Michael ^a   Schlieper, Georg ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART OUTPUT; HEMODIALYSIS PATIENT; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RISK FACTOR; SPECKLE TRACKING ECHOCARDIOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY; ULTRASOUND SCANNER; UREMIC CARDIOMYOPATHY; AGED; ANIMAL; CARDIOMYOPATHIES; CHRONIC KIDNEY FAILURE; COMPLICATION; ECHOGRAPHY; EPIDEMIOLOGY; FIBROSIS; GERMANY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; MIDDLE AGED; MORTALITY; OBSERVER VARIATION; PATHOLOGY; PROCEDURES; RETROSPECTIVE STUDY; WISTAR RAT;

AGED; ANIMALS; CARDIOMYOPATHIES; ECHOCARDIOGRAPHY; FEMALE; FIBROSIS; GERMANY; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYOCARDIUM; OBSERVER VARIATION; RATS, WISTAR; RETROSPECTIVE STUDIES; VENTRICULAR FUNCTION, LEFT;

EID: 84921741961     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013070734     Document Type: Article

References (67)

1. de Jager DJ, Grootendorst DC, Jager KJ, van Dijk PC, Tomas LM, Ansell D, Collart F, Finne P, Heaf JG, DeMeester J, Wetzels JF, Rosendaal FR, Dekker FW: Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 302: 1782-1789, 2009
2. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32[Suppl 3]: S112-S119, 1998
3. Foley RN, Parfrey PS, Sarnak MJ: Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 9[Suppl]: S16-S23, 1998
4. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD: Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 63: 793-808, 2003
5. Zoccali C: Left ventricular systolic dysfunction: A sudden killer in endstage renal disease patients. Hypertension 56: 187-188, 2010
6. Green D, Roberts PR, New DI, Kalra PA: Sudden cardiac death in hemodialysis patients: An in-depth review. Am J Kidney Dis 57: 921-929, 2011
7. U.S. Renal Data System. Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the US. Bethesda, MD, National Institutes of Health, Diabetes and Digestive and Kidney Disease, 2007.
8. Mizobuchi M, Nakamura H, Tokumoto M, Finch J,Morrissey J, Liapis H, Slatopolsky E: Myocardial effects of VDR activators in renal failure. J Steroid Biochem Mol Biol 121: 188-192, 2010
9. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Cataliotti A, Seminara G, Stancanelli B, Malatino LS: Prognostic value of echocardiographic indicators of left ventricular systolic function in asymptomatic dialysis patients. J Am Soc Nephrol 15: 1029-1037, 2004
10. Becker M, Kramann R, Dohmen G, Luckhoff A, Autschbach R, Kelm M, Hoffmann R: Impact of left ventricular loading conditions on myocardial deformation parameters: Analysis of early and late changes of myocardial deformation parameters after aortic valve replacement. J Am Soc Echocardiogr 20: 681-689, 2007
11. Leitman M, Lysyansky P, Sidenko S, Shir V, Peleg E, Binenbaum M, Kaluski E, Krakover R, Vered Z: Two-dimensional strain-a novel software for real-time quantitative echocardiographic assessment of myocardial function. J Am Soc Echocardiogr 17: 1021-1029, 2004
12. Carasso S, Agmon Y, Roguin A, Keidar Z, Israel O, Hammerman H, Lessick J: Left ventricular function and functional recovery early and late after myocardial infarction: A prospective pilot study comparing twodimensional strain, conventional echocardiography, and radionuclide myocardial perfusion imaging. J AmSoc Echocardiogr 26: 1235-1244, 2013
13. Shanks M, Thompson RB, Paterson ID, Putko B, Khan A, Chan A, Becher H, Oudit GY: Systolic and diastolic function assessment in fabry disease patients using speckle-tracking imaging and comparison with conventional echocardiographic measurements. J Am Soc Echocardiogr 26: 1407-1414, 2013
14. Fine NM, Crowson CS, Lin G, Oh JK, Villarraga HR, Gabriel SE: Evaluation of myocardial function in patients with rheumatoid arthritis using strain imaging by speckle-tracking echocardiography [published online ahead of print July 19, 2013]. Ann Rheum Dis doi: 10.1136/annrheumdis- 2013-203314
15. Cusmà Piccione M, Zito C, Bagnato G, Oreto G, Di Bella G, Bagnato G, Carerj S: Role of 2D strain in the early identi fication of left ventricular dysfunction and in the risk stratification of systemic sclerosis patients. Cardiovasc Ultrasound 11: 6, 2013
16. Becker M, Lenzen A, Ocklenburg C, Stempel K, Kühl H, Neizel M, Katoh M, Kramann R, Wildberger J, Kelm M, Hoffmann R: Myocardial deformation imaging based on ultrasonic pixel tracking to identify reversible myocardial dysfunction. J Am Coll Cardiol 51: 1473-1481, 2008
17. Richand V, Lafitte S, Reant P, Serri K, Lafitte M, Brette S, Kerouani A, Chalabi H, Dos Santos P, Douard H, Roudaut R: An ultrasound speckle tracking (two-dimensional strain) analysis of myocardial deformation in professional soccer players compared with healthy subjects and hypertrophic cardiomyopathy. Am J Cardiol 100: 128-132, 2007
18. Ng AC, Delgado V, Bertini M, van der Meer RW, Rijzewijk LJ, Hooi Ewe S, Siebelink HM, Smit JW, Diamant M, Romijn JA, de Roos A, Leung DY, Lamb HJ, Bax JJ:Myocardial steatosis and biventricular strain and strain rate imaging in patients with type 2 diabetes mellitus. Circulation 122: 2538-2544, 2010
19. Krämer J, Niemann M, Liu D, Hu K, Machann W, Beer M, Wanner C, Ertl G, Weidemann F: Two-dimensional speckle tracking as a non-invasive tool for identification of myocardial fibrosis in Fabry disease. Eur Heart J 34: 1587-1596, 2013
20. Saito M, Okayama H, Yoshii T, Higashi H, Morioka H, Hiasa G, Sumimoto T, Inaba S, Nishimura K, Inoue K, Ogimoto A, Shigematsu Y, Hamada M, Higaki J: Clinical significance of global two-dimensional strain as a surrogate parameter of myocardial fibrosis and cardiac events in patients with hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging 13: 617-623, 2012
21. Popovic ZB, Kwon DH, Mishra M, Buakhamsri A, Greenberg NL, Thamilarasan M, Flamm SD, Thomas JD, Lever HM, Desai MY: Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging. J Am Soc Echocardiogr 21: 1299-1305, 2008
22. Popović ZB, Benejam C, Bian J, Mal N, Drinko J, Lee K, Forudi F, Reeg R, Greenberg NL, Thomas JD, Penn MS: Speckle-tracking echocardiography correctly identifies segmental left ventricular dysfunction induced by scarring in a rat model of myocardial infarction. Am J Physiol Heart Circ Physiol 292: H2809-H2816, 2007
23. Kansal MM, Panse PM, Abe H, Caracciolo G, Wilansky S, Tajik AJ, Khandheria BK, Sengupta PP: Relationship of contrast-enhanced magnetic resonance imaging-derived intramural scar distribution and speckle tracking echocardiography-derived left ventricular two-dimensional strains. Eur Heart J Cardiovasc Imaging 13: 152-158, 2012
24. Peng Y, Popovic ZB, Sopko N, Drinko J, Zhang Z, Thomas JD, Penn MS: Speckle tracking echocardiography in the assessment ofmousemodels of cardiac dysfunction. Am J Physiol Heart Circ Physiol 297: H811-H820, 2009
25. Gross ML, Ritz E: Hypertrophy and fibrosis in the cardiomyopathy of uremia -beyond coronary heart disease. Semin Dial 21: 308-318, 2008
26. Kennedy DJ, Vetteth S, Periyasamy SM, Kanj M, Fedorova L, Khouri S, Kahaleh MB, Xie Z,Malhotra D, Kolodkin NI, Lakatta EG, Fedorova OV, Bagrov AY, Shapiro JI: Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy. Hypertension 47: 488-495, 2006
27. Flynn JT: Cardiovascular disease in children with chronic renal failure. Growth Hormone IGF Res 16[Suppl A]: S84-S90, 2006
28. London GM: Cardiovascular disease in chronic renal failure: Pathophysiologic aspects. Semin Dial 16: 85-94, 2003
29. Tian J, Shidyak A, Periyasamy SM, Haller S, Taleb M, El-Okdi N, Elkareh J, Gupta S, Gohara S, Fedorova OV, Cooper CJ, Xie Z, Malhotra D, Bagrov AY, Shapiro JI: Spironolactone attenuates experimental uremic cardiomyopathy by antagonizing marinobufagenin. Hypertension 54: 1313-1320, 2009
30. Haller ST, Drummond CA, Yan Y, Liu J, Tian J, Malhotra D, Shapiro JI: Passive immunization against marinobufagenin attenuates renal fibrosis and improves renal function in experimental renal disease [published online ahead of print September 6, 2013]. Am J Hypertens 10.1093/ajh/hpt169
31. Lekawanvijit S, Kompa AR, Manabe M, Wang BH, Langham RG, Nishijima F, Kelly DJ, Krum H: Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfate. PLoS ONE 7: e41281, 2012
32. Tyralla K, Adamczak M, Benz K, Campean V, Gross ML, Hilgers KF, Ritz E,Amann K: High-dose enalapril treatment reverses myocardial fibrosis in experimental uremic cardiomyopathy. PLoS ONE 6: e15287, 2011
33. Törnig J, Amann K, Ritz E, Nichols C, Zeier M, Mall G: Arteriolar wall thickening, capillary rarefaction and interstitial fibrosis in the heart of rats with renal failure: The effects of ramipril, nifedipine and moxonidine. J Am Soc Nephrol 7: 667-675, 1996
34. Vlahakos DV, Hahalis G, Vassilakos P, Marathias KP, Geroulanos S: Relationship between left ventricular hypertrophy and plasma renin activity in chronic hemodialysis patients. J Am Soc Nephrol 8: 1764-1770, 1997
35. Semple D, Smith K, Bhandari S, Seymour AM: Uremic cardiomyopathy and insulin resistance: A critical role for akt? J Am Soc Nephrol 22: 207-215, 2011
36. Semple DJ, Bhandari S, Seymour AM: Uremic cardiomyopathy is characterized by loss of the cardioprotective effects of insulin. Am J Physiol Renal Physiol 303: F1275-F1286, 2012
37. Amann K, Törnig J, Kugel B, Gross ML, Tyralla K, El-Shakmak A, Szabo A, Ritz E: Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia. Kidney Int 63: 1296-1301, 2003
38. Yamamoto KT, Robinson-Cohen C, de Oliveira MC, Kostina A, Nettleton JA, Ix JH, Nguyen H, Eng J, Lima JA, Siscovick DS,Weiss NS, Kestenbaum B: Dietary phosphorus is associated with greater left ventricular mass. Kidney Int 83: 707-714, 2013
39. Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, Gutiérrez OM, Aguillon-Prada R, Lincoln J, Hare JM, Mundel P,Morales A, Scialla J, Fischer M, Soliman EZ, Chen J, Go AS, Rosas SE, Nessel L, Townsend RR, Feldman HI, St John Sutton M, Ojo A, Gadegbeku C, DiMarco GS, Reuter S, Kentrup D, Tiemann K, Brand M, Hill JA,Moe OW, Kuro-OM, Kusek JW, Keane MG, Wolf M: FGF23 induces left ventricular hypertrophy. J Clin Invest 121: 4393-4408, 2011
40. Nguy L, Nilsson H, Lundgren J, Johansson ME, Teerlink T, Scheffer PG, Guron G: Vascular function in rats with adenine-induced chronic renal failure. Am J Physiol Regul Integr Comp Physiol 302: R1426-R1435, 2012
41. Katsumata K, Kusano K, Hirata M, Tsunemi K, Nagano N, Burke SK, Fukushima N: Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats. Kidney Int 64: 441-450, 2003
42. Kramann R, DiRocco DP, Humphreys BD: Understanding the origin, activation and regulation of matrix-producing myo fibroblasts for treatment of fibrotic disease. J Pathol 231: 273-289, 2013
43. Martin FL, McKie PM, Cataliotti A, Sangaralingham SJ, Korinek J, Huntley BK, Oehler EA, Harders GE, Ichiki T, Mangia fico S, Nath KA, Red field MM, Chen HH, Burnett JC Jr: Experimental mild renal insufficiency mediates early cardiac apoptosis, fibrosis, and diastolic dysfunction: A kidney-heart connection. Am J Physiol Regul Integr Comp Physiol 302: R292-R299, 2012
44. Pandya K, Kim HS, Smithies O: Fibrosis, not cell size, delineates betamyosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo. Proc Natl Acad Sci U S A 103: 16864-16869, 2006
45. Chaykovska L, von Websky K, Rahnenführer J, Alter M, Heiden S, Fuchs H, Runge F, Klein T, Hocher B: Effects of DPP-4 inhibitors on the heart in a rat model of uremic cardiomyopathy. PLoS ONE 6: e27861, 2011
46. Migrino RQ, Aggarwal D, Konorev E, Brahmbhatt T, Bright M, Kalyanaraman B: Early detection of doxorubicin cardiomyopathy using two-dimensional strain echocardiography. Ultrasound Med Biol 34: 208-214, 2008
47. Ersbøll M, Andersen MJ, Valeur N, Mogensen UM, Fahkri Y, Thune JJ, Møller JE, Hassager C, Søgaard P, Køber L: Early diastolic strain rate in relation to systolic and diastolic function and prognosis in acute myocardial infarction: a two-dimensional speckle-tracking study [published online ahead of print May 26, 2013]. Eur Heart J doi: 10.1093/eurheartj/eht179
48. Kimura K, Takenaka K, Ebihara A, Okano T, Uno K, Fukuda N, Ando J, Fujita H,Morita H, Yatomi Y, Nagai R: Speckle tracking global strain rate E/E' predicts LV filling pressure more accurately than traditional tissue Doppler E/E'. Echocardiography 29: 404-410, 2012
49. Azevedo CF, Amado LC, Kraitchman DL, Gerber BL, Osman NF, Rochitte CE, Edvardsen T, Lima JA: Persistent diastolic dysfunction despite complete systolic functional recovery after reperfused acute myocardial infarction demonstrated by tagged magnetic resonance imaging. Eur Heart J 25: 1419-1427, 2004
50. Schelbert EB,Hsu LY, Anderson SA, Mohanty BD, Karim SM, Kellman P, Aletras AH, Arai AE: Late gadolinium-enhancement cardiac magnetic resonance identifies postinfarction myocardial fibrosis and the border zone at the near cellular level in ex vivo rat heart. Circ Cardiovasc Imaging 3: 743-752, 2010
51. Reiter T, Ritter O, Prince MR, Nordbeck P, Wanner C, Nagel E, Bauer WR: Minimizing risk of nephrogenic systemic fi brosis in cardiovascular magnetic resonance. J Cardiovasc Magn Reson 14: 31, 2012
52. Cho GY, Marwick TH, Kim HS, Kim MK, Hong KS, Oh DJ: Global 2- dimensional strain as a newprognosticator in patients with heart failure. J Am Coll Cardiol 54: 618-624, 2009
53. Liu YW, Su CT, Huang YY, Yang CS, Huang JW, Yang MT, Chen JH, Tsai WC: Left ventricular systolic strain in chronic kidney disease and hemodialysis patients. Am J Nephrol 33: 84-90, 2011
54. Gulel O, Soylu K, Yuksel S, Karaoglanoglu M, Cengiz K, Dilek M, Hamiseyev C, Kale A, Arik N: Evidence of left ventricular systolic and diastolic dysfunction by color tissue Doppler imaging despite normal ejection fraction in patients on chronic hemodialysis program. Echocardiography 25: 569-574, 2008
55. Yan P, Li H, Hao C, Shi H, Gu Y, Huang G, Chen J: 2D-speckle tracking echocardiography contributes to early identification of impaired left ventricular myocardial function in patients with chronic kidney disease. Nephron Clin Pract 118: c232-c240, 2011
56. Edwards NC, Hirth A, Ferro CJ, Townend JN, Steeds RP: Subclinical abnormalities of left ventricular myocardial deformation in early-stage chronic kidney disease: The precursor of uremic cardiomyopathy? JAm Soc Echocardiogr 21: 1293-1298, 2008
57. Rakhit DJ, Zhang XH, Leano R, Armstrong KA, Isbel NM, Marwick TH: Prognostic role of subclinical left ventricular abnormalities and impact of transplantation in chronic kidney disease. AmHeart J 153: 656-664, 2007
58. Liu YW, Su CT, Sung JM, Wang SP, Su YR, Yang CS, Tsai LM, Chen JH, Tsai WC: Association of left ventricular longitudinal strain with mortality among stable hemodialysis patients with preserved left ventricular ejection fraction. Clin J Am Soc Nephrol 8: 1564-1574, 2013
59. Stoylen A, Heimdal A, Bjornstad K, Wiseth R, Vik-Mo H, Torp H, Angelsen B, Skjaerpe T: Strain rate imaging by ultrasonography in the diagnosis of coronary artery disease. J AmSoc Echocardiogr 13: 1053-1064, 2000
60. Saravanan P, Davidson NC: Risk assessment for sudden cardiac death in dialysis patients. Circ Arrhythm Electrophysiol 3: 553-559, 2010
61. Watson LE, Sheth M, Denyer RF, Dostal DE: Baseline echocardiographic values for adultmale rats. JAmSoc Echocardiogr 17: 161-167, 2004
62. Price PA, Roublick AM, Williamson MK: Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate. Kidney Int 70: 1577-1583, 2006
63. Slama M, Susic D, Varagic J, Ahn J, Frohlich ED: Echocardiographic measurement of cardiac output in rats. Am J Physiol Heart Circ Physiol 284: H691-H697, 2003
64. Pieper GM, Shah A, Harmann L, Cooley BC, Ionova IA, Migrino RQ: Speckle-tracking 2-dimensional strain echocardiography: A new noninvasive imaging tool to evaluate acute rejection in cardiac transplantation. J Heart Lung Transplant 29: 1039-1046, 2010
65. Kramann R, Couson SK, Neuss S, Kunter U, Bovi M, Bornemann J, Knüchel R, Jahnen-Dechent W, Floege J, Schneider RK: Exposure to uremic serum induces a procalcific phenotype in human mesenchymal stem cells. Arterioscler Thromb Vasc Biol 31: e45-e54, 2011
66. Becker M, Kramann R, Franke A, Breithardt OA, Heussen N, Knackstedt C, Stellbrink C, Schauerte P, Kelm M, Hoffmann R: Impact of left ventricular lead position in cardiac resynchronization therapy on left ventricular remodelling. A circumferential strain analysis based on 2D echocardiography. Eur Heart J 28: 1211-1220, 2007
67. Lin LI: A concordance correlation coefficient to evaluate reproducibility. Biometrics 45: 255-268, 1989